KEGG   PATHWAY: ko04728
ko04728                     Pathway                                

Dopaminergic synapse
Dopamine (DA) is an important and prototypical slow neurotransmitter in the mammalian brain, where it controls a variety of functions including locomotor activity, motivation and reward, learning and memory, and endocrine regulation. Once released from presynaptic axonal terminals, DA interacts with at least five receptor subtypes in the central nervous system (CNS), which have been divided into two groups: the D1-like receptors (D1Rs), comprising D1 and D5 receptors, both positively coupled to adenylyl cyclase and cAMP production, and the D2-like receptors (D2Rs), comprising D2, D3, and D4 receptors, whose activation results in inhibition of adenylyl cyclase and suppression of cAMP production. In addition, D1Rs and D2Rs modulate intracellular Ca2+ levels and a number of Ca2+ -dependent intracellular signaling processes. Through diverse cAMP- and Ca2+-dependent and - independent mechanisms, DA influences neuronal activity, synaptic plasticity, and behavior. Presynaptically localized D2Rs regulate synthesis and release of DA as the main autoreceptor of the dopaminergic system.
Organismal Systems; Nervous system
Pathway map
ko04728  Dopaminergic synapse

H00548  Brunner syndrome
H00606  Early infantile epileptic encephalopathy
H00749  Episodic ataxias
H00773  Autosomal dominant mental retardation
H00775  Hemiplegic migraine
H00783  Febrile seizures
H00831  Primary dystonia
H01161  Aromatic L-amino acid decarboxylase deficiency
H01450  Obsessive-compulsive disorder
H01649  Schizophrenia
H01671  Neurosis
H01818  Dravet syndrome
H01895  Attention deficit hyperactivity disorder (ADHD)
Other DBs
GO: 0001963
K00501  tyrosine 3-monooxygenase [EC:]
K01593  aromatic-L-amino-acid/L-tryptophan decarboxylase [EC:]
K08155  MFS transporter, DHA1 family, solute carrier family 18 (vesicular amine transporter), member 1/2
K04144  dopamine receptor D1
K05840  dopamine receptor D5
K15493  neuron-specific vesicular protein calcyon
K04634  guanine nucleotide-binding protein G(q) subunit alpha
K05858  phosphatidylinositol phospholipase C, beta [EC:]
K04958  inositol 1,4,5-triphosphate receptor type 1
K04959  inositol 1,4,5-triphosphate receptor type 2
K04960  inositol 1,4,5-triphosphate receptor type 3
K02183  calmodulin
K04515  calcium/calmodulin-dependent protein kinase (CaM kinase) II [EC:]
K04348  serine/threonine-protein phosphatase 2B catalytic subunit [EC:]
K02677  classical protein kinase C alpha type [EC:]
K19662  classical protein kinase C beta type [EC:]
K19663  classical protein kinase C gamma type [EC:]
K04379  proto-oncogene protein c-fos
K04632  guanine nucleotide-binding protein G(s) subunit alpha
K04633  guanine nucleotide-binding protein G(olf) subunit alpha
K08045  adenylate cyclase 5 [EC:]
K04345  protein kinase A [EC:]
K05870  cyclic AMP-responsive element-binding protein 1
K04450  cyclic AMP-dependent transcription factor ATF-2
K04374  cyclic AMP-dependent transcription factor ATF-4
K09048  cyclic AMP-responsive element-binding protein 3
K09047  cyclic AMP-responsive element-binding protein 5
K09049  cyclic AMP-dependent transcription factor ATF-6 beta
K04441  p38 MAP kinase [EC:]
K04440  mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:]
K15494  protein phosphatase 1 regulatory subunit 1B
K06269  serine/threonine-protein phosphatase PP1 catalytic subunit [EC:]
K04833  voltage-gated sodium channel type I alpha
K04850  voltage-dependent calcium channel L type alpha-1C
K04851  voltage-dependent calcium channel L type alpha-1D
K04344  voltage-dependent calcium channel P/Q type alpha-1A
K04849  voltage-dependent calcium channel N type alpha-1B
K04997  potassium inwardly-rectifying channel subfamily J member 3
K05000  potassium inwardly-rectifying channel subfamily J member 6
K05002  potassium inwardly-rectifying channel subfamily J member 9
K04999  potassium inwardly-rectifying channel subfamily J member 5
K04146  dopamine receptor D3
K04147  dopamine receptor D4
K04630  guanine nucleotide-binding protein G(i) subunit alpha
K04534  guanine nucleotide-binding protein G(o) subunit alpha
K04536  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1
K04537  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2
K07825  guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-3
K04538  guanine nucleotide-binding protein subunit beta-4
K04539  guanine nucleotide-binding protein subunit beta-5
K07826  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2
K04540  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-3
K04541  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-4
K04542  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5
K04543  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-7
K04544  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-8
K04545  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10
K04546  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-11
K04347  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12
K04547  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-13
K04548  guanine nucleotide-binding protein G(T) subunit gamma-T1
K04549  guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2
K04145  dopamine receptor D2
K04439  beta-arrestin
K04382  serine/threonine-protein phosphatase 2A catalytic subunit [EC:]
K03456  serine/threonine-protein phosphatase 2A regulatory subunit A
K04354  serine/threonine-protein phosphatase 2A regulatory subunit B
K11583  serine/threonine-protein phosphatase 2A regulatory subunit B''
K11584  serine/threonine-protein phosphatase 2A regulatory subunit B'
K04456  RAC serine/threonine-protein kinase [EC:]
K08822  glycogen synthase kinase 3 alpha [EC:]
K03083  glycogen synthase kinase 3 beta [EC:]
K05209  glutamate receptor ionotropic, NMDA 2A
K05210  glutamate receptor ionotropic, NMDA 2B
K05197  glutamate receptor 1
K05198  glutamate receptor 2
K05199  glutamate receptor 3
K05200  glutamate receptor 4
K10396  kinesin family member 5
K02223  circadian locomoter output cycles kaput protein [EC:]
K02296  aryl hydrocarbon receptor nuclear translocator-like protein 1
K05036  solute carrier family 6 (neurotransmitter transporter, dopamine) member 3
K00274  monoamine oxidase [EC:]
K00545  catechol O-methyltransferase [EC:]
C00076  Calcium cation
C00082  L-Tyrosine
C00165  Diacylglycerol
C00238  Potassium cation
C00355  3,4-Dihydroxy-L-phenylalanine
C00575  3',5'-Cyclic AMP
C01161  3,4-Dihydroxyphenylacetate
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01330  Sodium cation
C03758  Dopamine
C05582  Homovanillate
C05587  3-Methoxytyramine
Beaulieu JM, Gainetdinov RR
The physiology, signaling, and pharmacology of dopamine receptors.
Pharmacol Rev 63:182-217 (2011)
Neve KA, Seamans JK, Trantham-Davidson H
Dopamine receptor signaling.
J Recept Signal Transduct Res 24:165-205 (2004)
Surmeier DJ, Ding J, Day M, Wang Z, Shen W
D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.
Trends Neurosci 30:228-35 (2007)
Knab AM, Lightfoot JT
Does the difference between physically active and couch potato lie in the dopamine system?
Int J Biol Sci 6:133-50 (2010)
Greengard P, Allen PB, Nairn AC
Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade.
Neuron 23:435-47 (1999)
Hu XT, Dong Y, Zhang XF, White FJ
Dopamine D2 receptor-activated Ca2+ signaling modulates voltage-sensitive sodium currents in rat nucleus accumbens neurons.
J Neurophysiol 93:1406-17 (2005)
Beaulieu JM, Gainetdinov RR, Caron MG
The Akt-GSK-3 signaling cascade in the actions of dopamine.
Trends Pharmacol Sci 28:166-72 (2007)
De Mei C, Ramos M, Iitaka C, Borrelli E
Getting specialized: presynaptic and postsynaptic dopamine D2 receptors.
Curr Opin Pharmacol 9:53-8 (2009)
Seamans JK, Yang CR
The principal features and mechanisms of dopamine modulation in the prefrontal cortex.
Prog Neurobiol 74:1-58 (2004)
Yao WD, Spealman RD, Zhang J
Dopaminergic signaling in dendritic spines.
Biochem Pharmacol 75:2055-69 (2008)
Li YC, Gao WJ
GSK-3beta activity and hyperdopamine-dependent behaviors.
Neurosci Biobehav Rev 35:645-54 (2011)
Tang TS, Bezprozvanny I
Dopamine receptor-mediated Ca(2+) signaling in striatal medium spiny neurons.
J Biol Chem 279:42082-94 (2004)
Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS
Dopamine receptor-interacting proteins: the Ca(2+) connection in dopamine signaling.
Trends Pharmacol Sci 24:486-92 (2003)
Missale C, Nash SR, Robinson SW, Jaber M, Caron MG
Dopamine receptors: from structure to function.
Physiol Rev 78:189-225 (1998)
Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ
Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?
Eur Respir J 33:468-80 (2009)
ko00350  Tyrosine metabolism
ko04020  Calcium signaling pathway
ko04721  Synaptic vesicle cycle
ko04724  Glutamatergic synapse
ko05012  Parkinson disease

DBGET integrated database retrieval system